Drug record
What four public record sets show for oxycodone. Saved Nov 10, 2026.
| Shortage | Not on the FDA shortage list | Details |
|---|---|---|
| Pharmacy cost | $0.092 each for the lowest-cost generic | Details |
| Medicare Part D, 2024 | $708.0 million | Details |
| FDA recall records | 25 | Details |
Whether the FDA lists this drug as in short supply.
The list changes daily, and it covers the national supply. A pharmacy near you can be out of a drug that is not listed, or have one that is. See today's status.
The national average price retail pharmacies pay to buy it (NADAC).
The lowest-cost generic on file is Oxycodone Hcl (Ir) 5 Mg Tablet: pharmacies pay about $0.092 each, or $2.77 for 30.
| Product as surveyed | Type | Pharmacy pays | For 30 | Price since |
|---|---|---|---|---|
| OXYCODONE HCL (IR) 10 MG TAB | Generic | $0.156 per each | $4.69 | Oct 21, 2026 |
| OXYCODONE HCL (IR) 15 MG TAB | Generic | $0.199 per each | $5.98 | Oct 21, 2026 |
| OXYCODONE HCL (IR) 20 MG TAB | Generic | $0.258 per each | $7.75 | Oct 21, 2026 |
| OXYCODONE HCL (IR) 30 MG TAB | Generic | $0.361 per each | $10.83 | Oct 21, 2026 |
| OXYCODONE HCL (IR) 5 MG CAP | Generic | $0.382 per each | $11.45 | Oct 21, 2026 |
| OXYCODONE HCL (IR) 5 MG TABLET | Generic | $0.092 per each | $2.77 | Oct 21, 2026 |
| OXYCODONE HCL 100 MG/5 ML CONC | Generic | $2.26 per mL | — | Oct 21, 2026 |
| OXYCODONE HCL 5 MG/5 ML SOLN | Generic | $0.050 per mL | — | Oct 21, 2026 |
| OXYCONTIN ER 10 MG TABLET | Brand | $5.87 per each | $176.23 | Oct 21, 2026 |
| OXYCONTIN ER 15 MG TABLET | Brand | $8.66 per each | $259.68 | Oct 21, 2026 |
| OXYCONTIN ER 20 MG TABLET | Brand | $10.95 per each | $328.60 | Oct 21, 2026 |
| OXYCONTIN ER 30 MG TABLET | Brand | $15.22 per each | $456.72 | Oct 21, 2026 |
| OXYCONTIN ER 40 MG TABLET | Brand | $18.77 per each | $563.14 | Oct 21, 2026 |
| OXYCONTIN ER 60 MG TABLET | Brand | $26.53 per each | $796.03 | Oct 21, 2026 |
| OXYCONTIN ER 80 MG TABLET | Brand | $32.64 per each | $979.21 | Oct 21, 2026 |
| ROXICODONE 15 MG TABLET | Brand | $5.47 per each | $163.96 | Oct 21, 2026 |
| ROXICODONE 30 MG TABLET | Brand | $10.70 per each | $321.03 | Sep 23, 2026 |
This is not your price. NADAC is the national average that retail pharmacies pay to buy the drug, from the Medicaid survey for the week of Nov 11, 2026. What you pay adds the pharmacy's markup and dispensing fee and depends on your insurance or any discount card. "For 30" is shown only for products priced per tablet or capsule. Brand prices here are before any rebates.
Medicare Part D spending by product, from the latest annual file (2024).
In 2024, Medicare Part D plans and their members paid $708.0 million for the 7 products below. That is down 22% from $908.6 million in 2020.
| Product | 2024 spending | People | Per prescription | Per person, year | 2020 spending |
|---|---|---|---|---|---|
| Oxycontin Oxycodone HCl | $337.8 million | 61,465 | $712.45 | $5,495.07 | $558.7 million |
| Xtampza ER Oxycodone Myristate | $232.8 million | 50,981 | $627.20 | $4,565.44 | $161.3 million |
| Oxycodone HCl Oxycodone HCl | $132.8 million | 2,778,630 | $14.50 | $47.81 | $168.8 million |
| Roxybond Oxycodone HCl | $2.2 million | 425 | $1,657.56 | $5,261.29 | — |
| Roxicodone Oxycodone HCl | $1.6 million | 177 | $1,072.67 | $9,241.89 | $3.0 million |
| Oxycodone HCl ER Oxycodone HCl | $806,762 | 1,334 | $387.87 | $604.77 | $14.8 million |
| Oxaydo Oxycodone HCl | $9,834 | 25 | $364.22 | $393.36 | $2.0 million |
Spending is the gross amount paid at the pharmacy by Part D plans and patients, before manufacturer rebates, which can be large for brand drugs. The same person can use more than one product, so people are not added up across rows. A dash means the file suppresses a small number or has no figure for that year. Not counted here, combination products that contain it: Endocet, Nalocet, Oxycodone-Acetaminophen, Percocet, Prolate.
Recalls reported to the FDA that name this drug.
The FDA has 25 recall records that name oxycodone in the product description (1 Class I · 12 Class II · 12 Class III). 4 are still marked ongoing.
Oxycodone Hydrochloride Tablets, USP (CII), 5 mg, 100-Count (10 x 10) blister cards per carton, Rx Only, The drug product contained in this package is from NDC # 10702-018, KVK-Tech Inc. Distributed by: American Health Packaging, Columbus, Ohio 43217, Carton NDC 68084-354-01; Blister NDC 68084-354-11
Reason: Defective container: card seal defects (weak/non-existent seals), leading to the tablets falling out of their cavities.
Oxycodone and Acetaminophen CII Tablets USP, 10mg/325 mg, 100 tablets, Rx only, SpecGx LLC, Webster Groves, MO 63119, NDC 0406-0523-01.
Reason: Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets.
Oxycodone and Acetaminophen CII Tablets USP, 7.5 mg/325 mg, 100 tablets, Rx only, SpecGx LLC, Webster Groves, MO 63119, NDC 0406-0522-01. Case label: SpecGx LLC, NDC 0406052201, Exp. 2027/03, Lot: 0522J23493
Reason: Failed Tablet/Capsule Specification: There is a potential for the imprint to be missing on tablets.
Oxaydo (oxycodone HCl, USP) tablets, 7.5 mg, 100 Tablets per bottle, Rx only, Distributed by: Zyla Life Sciences US Inc., Wayne, PA 19087. NDC: 69344-213-11
Reason: Sub-potent Drug: Lower potency than labeled.
Oxycodone Hydrochloride Oral Solution, USP (C-II), 5 mg/5 mL, Delivers 5 mL per Cup, 1 Tray of 10 Cups, Rx Only, For Institutional Use Only, American Health Packaging, Columbus, OH 43217. UPC (01) 003 60687 406 40 4; Case NDC#: 60687-406-77, Unit Dose NDC#: 60687-406-40
Reason: Impurity failure at 0-time of the repackaged lot.
Oxycodone Hydrochloride Oral Solution, USP 5 mg per 5 mL (1 mg/mL), 500 mL bottle, Rx only, Manufactured by: Hi-Tech Pharmacal Co., Inc., Amityville, NY 11701 --- NDC 50383-961-34
Reason: Labeling: Missing Label
Oxycodone Hydrochloride Tablets, USP C-II, 5 mg, 100 count bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, MD 21202. Manufactured by: Novel Laboratories, Inc. Somerset, NJ 08873. NDC 43386-432-01
Reason: Out-of-specification impurity test result observed at 18-month long term stability time point.
Oxycodone Hydrochloride Tablets, USP, 10 mg, 100 count bottle, Rx only, Marketed by: Rhodes Pharmaceuticals L.P., Coventry RI 02816, Manufactured by: Purdue Pharma L.P., Stanford, CT 06901 NDC 42858-002-01
Reason: Presence of Foreign Tablets/Capsules; A single foreign tablet Hydrochlorothiazide/Lisinopril 25/20 was found in one bottle
Oxycodone Hydrochloride Oral Solution, USP 5 mg/5mL unit dose cups, Rx Only, Genus Lifesciences Inc. NDC 64950-354-05 Case NDC: 64950-354-450(40 unit dose cups) Case NDC 64950-354-55 (50 unit dose cups)
Reason: Presence of Foreign Substance: Particulate matter was found in multiple lots of product.
Oxycodone and Acetaminophen Tablets, USP 10 mg*/325 mg 100-count bottles, Rx Only, Distributed by: Aurobindo Pharma USA, Inc. Dayton, NJ 08810, NDC 13107-046-01
Reason: CGMP Deviations: Products were manufactured in a processing area in which water leakage was observed
Oxycodone and Acetaminophen Tablets, USP, 5 mg*/325 mg, 100-count bottle, Rx Only, Manufactured by: Mayne Pharma, Greenville, NC 27834, NDC 68308-841-01.
Reason: Labeling: Incorrect or Missing Lot and/or Exp Date: Lot FG10517 is mislabeled on the primary container with Lot FG01517, shipper labels and invoices contain the correct lot number of FG10517.
Oxycodone Hydrochloride Tablets, USP 15 mg, 100 count bottles, Rx only, Manufactured for Camber Pharmaceuticals, Inc., Piscataway, NJ, Manufactured by: Ascent Pharmaceuticals, Inc., Central Islip, NY --- NDC 31722-917-01
Reason: Labeling; Label Error Not Elsewhere Classified; label missing controlled substance CII symbol
A recall covers specific lots from one company, not every bottle of the drug. Records include combination products and compounded versions that name this ingredient. Class I is the most serious: use could cause serious harm. Class II may cause temporary or reversible harm. Class III is unlikely to cause harm. To check a bottle, match the lot number on the label. See the live list. Do not stop a medicine because of a recall without asking your pharmacist.
These are saved records as of Nov 10, 2026; the sources update daily to yearly. For current figures open the live report for oxycodone. This page is public-record information, not medical advice.